Vaccine prevention of cancer: can endogenous antigens be targeted? - Test2 - elhamkhani - TriplyDB

Vaccine prevention of cancer: can endogenous antigens be targeted?

Vaccine prevention of cancer: can endogenous antigens be targeted?

http://www.wikidata.org/entity/Q33783609

about

Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunoprevention Crystal ball - 2011 Stimulation of anti-tumor immunity by photodynamic therapy Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma.Overexpressed oncogenic tumor-self antigens Intratumoral delivery of low doses of anti-CD40 mAb combined with monophosphoryl lipid a induces local and systemic antitumor effects in immunocompetent and T cell-deficient mice.What is recent in pancreatic cancer immunotherapy?Potential targets for pancreatic cancer immunotherapeutics.Progress in Vaccine Therapies for Breast Cancer.

P2860

Q28082487-823F02BE-060C-4B82-9DBE-F524C7200354 Q28661746-33A2ECFA-3A63-4039-B2F7-E0CDC7743C04 Q34697795-4CE575AA-C703-4FB4-9AC3-41079C3CA18A Q35147489-F752EF36-E637-4130-BADA-A25AE3EF96A4 Q35886756-29B466DF-3639-4702-B139-18B36EF85A2A Q36465489-59501145-EB2A-4B92-AD53-BF64F5DA7B41 Q36665335-C02C0001-5925-46BD-A470-1BF28A91BAF2 Q37861220-18CF8075-132D-4C89-B7FD-CFA891236F5E Q48556381-485CC69C-61A8-4C51-95AF-A09906D361B6

P2860

Vaccine prevention of cancer: can endogenous antigens be targeted?

http://www.wikidata.org/entity/Q33783609

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Vaccine prevention of cancer: can endogenous antigens be targeted?

@ast

Vaccine prevention of cancer: can endogenous antigens be targeted?

@en

type

label

Vaccine prevention of cancer: can endogenous antigens be targeted?

@ast

Vaccine prevention of cancer: can endogenous antigens be targeted?

@en

prefLabel

Vaccine prevention of cancer: can endogenous antigens be targeted?

@ast

Vaccine prevention of cancer: can endogenous antigens be targeted?

@en

P1433

Q33783609-46D86209-B0F0-4AB0-A305-2CEB0B13661E

P1476

Q33783609-83CEB4F5-0213-4D2D-A69D-2F6016A548F6

P2093

Q33783609-59856BAF-D7B2-46C7-8935-5ADA287DF11C

Q33783609-AB31B652-D062-4C6C-A5FC-F7BAB2E643E5

Q33783609-D5352F41-55D4-444A-BCAC-AF2A2F07B1C8

P2860

Q33783609-0F8B01D8-2D93-463F-946E-01B38C9B4E8C

Q33783609-1049B9DF-6363-4E39-9EB2-9A52831881E9

Q33783609-1959EA8C-7090-4686-9D84-F5408FAA3B4E

Q33783609-1EAA93E3-B119-4523-829E-22BEC76D1BCB

Q33783609-26332BEF-D9CA-49AC-9DAD-F363D6B2983B

Q33783609-2F4FABDB-3607-4FD5-86E9-6B9EBF6CC55B

Q33783609-3493C196-FB06-4C39-B1A8-96BFC90CAEAC

Q33783609-3B756A0C-75D1-449C-A54E-BFD05403242B

Q33783609-3FF5ADE5-51B8-4C6C-AE7A-3811F259F8FC

Q33783609-485DFF4A-BF91-416C-B10A-41540E3080FD

P304

Q33783609-40689DE9-4AF6-4632-85C7-BFA9B7C9D4B6

P31

Q33783609-248621C4-6D9C-4E89-94A8-2268B35E4B6C

P356

Q33783609-6C017027-493C-413B-9103-04697056F1A1

P433

Q33783609-3719CE48-44AB-4E41-B5AE-BAC57D6E694A

P478

Q33783609-BAF84279-26FB-4D0F-BAA1-E3B7788C4557

P577

Q33783609-56EA2452-B5BB-47F7-80BD-164DA52A51EC

P698

Q33783609-E9FCAE05-1C46-4B07-97F4-C72A5CA5147D

P932

Q33783609-C85E0D5E-B814-4A50-9335-724D3CBD9EAE

P356

1940-6207.CAPR-10-0040

P1433

Cancer Prevention Research

P1476

Vaccine prevention of cancer: can endogenous antigens be targeted?

@en

P2093

Joseph Murray

http://www.w3.org/2001/XMLSchema#string

Louis M Weiner

http://www.w3.org/2001/XMLSchema#string

Rishi Surana

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer; a biological approach. I. The processes of control

The genomic landscapes of human breast and colorectal cancers

Celecoxib for the prevention of colorectal adenomatous polyps

A "NEW" ANTIGEN IN LEUKEMIA SERA

A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer

Cancer immunoediting: from immunosurveillance to tumor escape

Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

P304

410-415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-10-0040

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20332297

http://www.w3.org/2001/XMLSchema#string

P932

2853240

http://www.w3.org/2001/XMLSchema#string